Open Data Revolution in Clinical Research: Opportunities and Challenges
Efforts for sharing individual clinical data are gaining momentum due to a heightened recognition that integrated data sets can catalyze biomedical discoveries and drug development. Among the benefits are the fact that data sharing can help generate and investigate new research hypothesis beyond tho...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Clinical and Translational Science |
Online Access: | https://doi.org/10.1111/cts.12756 |
id |
doaj-7a8c30b9e10b483fbfa7e66b200ec0a3 |
---|---|
record_format |
Article |
spelling |
doaj-7a8c30b9e10b483fbfa7e66b200ec0a32020-11-25T03:01:43ZengWileyClinical and Translational Science1752-80541752-80622020-07-0113466567410.1111/cts.12756Open Data Revolution in Clinical Research: Opportunities and ChallengesMohamed H. Shahin0Sanchita Bhattacharya1Diego Silva2Sarah Kim3Jackson Burton4Jagdeep Podichetty5Klaus Romero6Daniela J. Conrado7Pfizer Global Research Groton Connecticut USABakar Computational Health Sciences Institute University of California, San Francisco San Francisco California USAFaculty of Health Sciences Simon Fraser University Vancouver British Columbia CanadaCenter for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics College of Pharmacy University of Florida Orlando Florida USACritical Path Institute Tucson Arizona USACritical Path Institute Tucson Arizona USACritical Path Institute Tucson Arizona USAe‐Quantify La Jolla California USAEfforts for sharing individual clinical data are gaining momentum due to a heightened recognition that integrated data sets can catalyze biomedical discoveries and drug development. Among the benefits are the fact that data sharing can help generate and investigate new research hypothesis beyond those explored in the original study. Despite several accomplishments establishing public systems and guidance for data sharing in clinical trials, this practice is not the norm. Among the reasons are ethical challenges, such as privacy of individuals, data ownership, and control. This paper creates awareness of the potential benefits and challenges of sharing individual clinical data, how to overcome these challenges, and how as a clinical pharmacology community we can shape future directions in this field.https://doi.org/10.1111/cts.12756 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mohamed H. Shahin Sanchita Bhattacharya Diego Silva Sarah Kim Jackson Burton Jagdeep Podichetty Klaus Romero Daniela J. Conrado |
spellingShingle |
Mohamed H. Shahin Sanchita Bhattacharya Diego Silva Sarah Kim Jackson Burton Jagdeep Podichetty Klaus Romero Daniela J. Conrado Open Data Revolution in Clinical Research: Opportunities and Challenges Clinical and Translational Science |
author_facet |
Mohamed H. Shahin Sanchita Bhattacharya Diego Silva Sarah Kim Jackson Burton Jagdeep Podichetty Klaus Romero Daniela J. Conrado |
author_sort |
Mohamed H. Shahin |
title |
Open Data Revolution in Clinical Research: Opportunities and Challenges |
title_short |
Open Data Revolution in Clinical Research: Opportunities and Challenges |
title_full |
Open Data Revolution in Clinical Research: Opportunities and Challenges |
title_fullStr |
Open Data Revolution in Clinical Research: Opportunities and Challenges |
title_full_unstemmed |
Open Data Revolution in Clinical Research: Opportunities and Challenges |
title_sort |
open data revolution in clinical research: opportunities and challenges |
publisher |
Wiley |
series |
Clinical and Translational Science |
issn |
1752-8054 1752-8062 |
publishDate |
2020-07-01 |
description |
Efforts for sharing individual clinical data are gaining momentum due to a heightened recognition that integrated data sets can catalyze biomedical discoveries and drug development. Among the benefits are the fact that data sharing can help generate and investigate new research hypothesis beyond those explored in the original study. Despite several accomplishments establishing public systems and guidance for data sharing in clinical trials, this practice is not the norm. Among the reasons are ethical challenges, such as privacy of individuals, data ownership, and control. This paper creates awareness of the potential benefits and challenges of sharing individual clinical data, how to overcome these challenges, and how as a clinical pharmacology community we can shape future directions in this field. |
url |
https://doi.org/10.1111/cts.12756 |
work_keys_str_mv |
AT mohamedhshahin opendatarevolutioninclinicalresearchopportunitiesandchallenges AT sanchitabhattacharya opendatarevolutioninclinicalresearchopportunitiesandchallenges AT diegosilva opendatarevolutioninclinicalresearchopportunitiesandchallenges AT sarahkim opendatarevolutioninclinicalresearchopportunitiesandchallenges AT jacksonburton opendatarevolutioninclinicalresearchopportunitiesandchallenges AT jagdeeppodichetty opendatarevolutioninclinicalresearchopportunitiesandchallenges AT klausromero opendatarevolutioninclinicalresearchopportunitiesandchallenges AT danielajconrado opendatarevolutioninclinicalresearchopportunitiesandchallenges |
_version_ |
1724692470878437376 |